Capricor: The FDA's Objections Change My June Buy To A Sell

Capricor's FDA objections lead to a downgrade from 'buy' to 'sell' for the stock.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.